Clarissa Carmona de Azevedo Bellagamba

Dr. Clarissa Carmona de Azevedo Bellagamba

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 March 2021 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
QCQuirino Ciampi
Quirino Ciampi
Iacopo OlivottoIacopo Olivotto
Iacopo Olivotto
JPJesus Peteiro
Jesus Peteiro
MDMaria Grazia D’alfonso
Maria Grazia D’alfonso
FMFabio Mori
Fabio Mori
T(the Stress Echo 2020 Study Group on behalf of the Italian Society of Echocardiography and Cardiovascular Imaging (SIECVI)
the Stress Echo 2020 Study Group on behalf of the Italian Society of Echocardiography and Cardiovascular Imaging (SIECVI)
Background: Sympathetic dysfunction can be evaluated by heart rate reserve (HRR) with exercise test. Objectives: To determine the value of HRR in predicting outcome of patients with hypertrophic cardiomyopathy (HCM). Methods: We enrolled 917 HCM patients (age = 49 ± 15 years, 516 men) assessed with exercise stress echocardiography (ESE) in 11 centres. ESE modality was semi-supine bicycle in 51 patients (6%), upright bicycle in 476 (52%), and treadmill in 390 (42%). During ESE, we assessed left ventricular outflow tract obstruction (LVOTO), stress-induced new regional wall motion abnormalities (RWMA), and HRR (peak/rest heart rate, HR). By selection, all patients completed the follow-up. Mortality was the predetermined outcome measure Results: During ESE, RWMA occurred in 22 patients (2.4%) and LVOTO (≥50 mmHg) in 281 (30.4%). HRR was 1.90 ± 0.40 (lowest quartile ≤ 1.61, highest quartile > 2.13). Higher resting heart rate (odds ratio 1.027, 95% CI: 1.018–1.036, p < 0.001), older age (odds ratio 1.021, 95% CI: 1.009–1.033, p < 0.001), lower exercise tolerance (mets, odds ratio 0.761, 95% CI: 0.708–0.817, p < 0.001) and resting LVOTO (odds ratio 1.504, 95% CI: 1.043–2.170, p = 0.029) predicted a reduced HRR. During a median follow-up of 89 months (interquartile range: 36–145 months), 90 all-cause deaths occurred. At multivariable analysis, lowest quartile HRR (Hazard ratio 2.354, 95% CI 1.116–4.968 p = 0.025) and RWMA (Hazard ratio 3.279, 95% CI 1.441–7.461 p = 0.004) independently predicted death, in addition to age (Hazard ratio 1.064, 95% CI 1.043–1.085 p < 0.001) and maximal wall thickness (Hazard ratio 1.081, 95% CI 1.037–1.128, p < 0.001). Conclusions: A blunted HRR during ESE predicts survival independently of RWMA in HCM patients.

25 September 2018 in Cardiovascular Ultrasound
Verified
Journal Article
Open access
PDF file
MSMaria Chiara Scali
Maria Chiara Scali
QCQuirino Ciampi
Quirino Ciampi
EPEugenio Picano
Eugenio Picano
EBEduardo Bossone
Eduardo Bossone
FFFrancesco Ferrara
Francesco Ferrara
CCClara Carpeggiani
Clara Carpeggiani
The effectiveness trial “Stress echo (SE) 2020” evaluates novel applications of SE in and beyond coronary artery disease. The core protocol also includes 4-site simplified scan of B-lines by lung ultrasound, useful to assess pulmonary congestion. To provide web-based upstream quality control and harmonization of B-lines reading criteria. 60 readers (all previously accredited for regional wall motion, 53 B-lines naive) from 52 centers of 16 countries of SE 2020 network read a set of 20 lung ultrasound video-clips selected by the Pisa lab serving as reference standard, after taking an obligatory web-based learning 2-h module ( http://se2020.altervista.org ). Each test clip was scored for B-lines from 0 (black lung, A-lines, no B-lines) to 10 (white lung, coalescing B-lines). The diagnostic gold standard was the concordant assessment of two experienced readers of the Pisa lab. The answer of the reader was considered correct if concordant with reference standard reading ±1 (for instance, reference standard reading of 5 B-lines; correct answer 4, 5, or 6). The a priori determined pass threshold was 18/20 (≥ 90%) with R value (intra-class correlation coefficient) between reference standard and recruiting center) > 0.90. Inter-observer agreement was assessed with intra-class correlation coefficient statistics. All 60 readers were successfully accredited: 26 (43%) on first, 24 (40%) on second, and 10 (17%) on third attempt. The average diagnostic accuracy of the 60 accredited readers was 95%, with R value of 0.95 compared to reference standard reading. The 53 B-lines naive scored similarly to the 7 B-lines expert on first attempt (90 versus 95%, p = NS). Compared to the step-1 of quality control for regional wall motion abnormalities, the mean reading time per attempt was shorter (17 ± 3 vs 29 ± 12 min, p < .01), the first attempt success rate was higher (43 vs 28%, p < 0.01), and the drop-out of readers smaller (0 vs 28%, p < .01). Web-based learning is highly effective for teaching and harmonizing B-lines reading. Echocardiographers without previous experience with B-lines learn quickly.

11 April 2019 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
MTMarco Antonio Rodrigues Torres
Marco Antonio Rodrigues Torres
TTThais F. Texeira
Thais F. Texeira
ACAna C. Camarozano
Ana C. Camarozano
Clarissa Carmona de Azevedo BellagambaClarissa Carmona de Azevedo Bellagamba
Clarissa Carmona de Azevedo Bellagamba
NQNatalia M. Quevedo
Natalia M. Quevedo
TIthe Stress Echo 2020 study group of the Italian Society of Cardiovascular Imaging
the Stress Echo 2020 study group of the Italian Society of Cardiovascular Imaging

1 March 2024 in Circulation: Heart Failure
Verified
Journal Article
Closed access
AFAnnamaria Del Franco
Annamaria Del Franco
Eszter Dalma PalinkasEszter Dalma Palinkas
Eszter Dalma Palinkas
Clarissa Carmona de Azevedo BellagambaClarissa Carmona de Azevedo Bellagamba
Clarissa Carmona de Azevedo Bellagamba
GBGiulia Biagioni
Giulia Biagioni
MZmattia zampieri
mattia zampieri
Iacopo OlivottoIacopo Olivotto
Iacopo Olivotto

29 October 2025 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Maria Concetta PastoreMaria Concetta Pastore
Maria Concetta Pastore
Clarissa Carmona de Azevedo BellagambaClarissa Carmona de Azevedo Bellagamba
Clarissa Carmona de Azevedo Bellagamba
RLRiccardo Liga
Riccardo Liga
ASAndrea Stefanini
Andrea Stefanini
MDMiriam Durante
Miriam Durante
Matteo CameliMatteo Cameli
Matteo Cameli
Arterial hypertension (HTN) represents the major cardiovascular risk factor and still represents a global health issue. In the last two years, three international societies published the new guidelines for the treatment of HTN (European Society of Cardiology, 2025; European Society of Hypertension, 2023; and American College of Cardiology in collaboration with American Heart Association, 2025), with many novelties which have been the object of many discussions among experts. The increased stress on screening programs, the new lower targets to reach by medical treatment, and the new strategies for resistant hypertension have raised some doubt on the feasibility of these recommendations in clinical practice. In this perspective document, the authors highlight and discuss the novelties and potential pros and cons of the new international recommendations for the treatment of arterial HTN.

18 August 2026 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Maria Concetta PastoreMaria Concetta Pastore
Maria Concetta Pastore
Clarissa Carmona de Azevedo BellagambaClarissa Carmona de Azevedo Bellagamba
Clarissa Carmona de Azevedo Bellagamba
ASAndrea Stefanini
Andrea Stefanini
APAlessia Pinelli
Alessia Pinelli
Giulia Elena MandoliGiulia Elena Mandoli
Giulia Elena Mandoli
Matteo CameliMatteo Cameli
Matteo Cameli
Heart failure with preserved ejection fraction (HFpEF) represents an increasingly prevalent clinical syndrome, driven by population ageing and the growing burden of cardiometabolic comorbidities, and is associated with significant morbidity and mortality. Due to its heterogeneous pathophysiology and the frequent absence of overt structural abnormalities, early diagnosis and accurate risk stratification remain challenging. In the current era of emerging disease-modifying therapies, the identification of sensitive imaging markers able to detect early myocardial dysfunction and refine patient characterization has become increasingly important. Speckle-tracking echocardiography has emerged as a valuable tool for the comprehensive evaluation of HFpEF, allowing the assessment of subclinical myocardial impairment beyond conventional parameters. Left ventricular global longitudinal strain (LV-GLS) identifies subtle systolic dysfunction despite preserved left ventricular ejection fraction (LVEF) and provides incremental diagnostic and prognostic information. Accordingly, LV-GLS has been incorporated into contemporary diagnostic algorithms and may represent a promising marker for monitoring disease progression and therapeutic response. Beyond the left ventricle (LV), left atrial (LA) strain has gained increasing relevance as a marker of atrial myopathy and elevated filling pressures. Left atrial reservoir strain (LARS) detects early atrial dysfunction before overt structural remodelling, improves the identification of HFpEF in patients with unexplained dyspnoea, and provides additional prognostic information, including prediction of atrial fibrillation and thromboembolic risk. Moreover, right ventricular free-wall longitudinal strain (RV-FWLS) allows early recognition of right ventricular involvement and has shown important prognostic implications, particularly in relation to pulmonary vascular dysfunction and exercise intolerance. Overall, a multi-chamber strain-based approach may improve HFpEF diagnosis, phenotyping, and risk stratification, supporting a transition toward a more personalized management strategy. Further prospective studies are needed to define the role of strain imaging in guiding therapeutic decisions and monitoring treatment response.